Calprotectin impairs platelet survival in patients with primary antiphospholipid syndrome

ConclusionsThese data suggest that calprotectin has the potential to be a functional biomarker and a new therapeutic target for APS thrombocytopenia.

Source: Arthritis and Rheumatology - January 16, 2024 Category: Rheumatology Authors: Claire K. Hoy, Somanathapura K. NaveenKumar, Sherwin A. Navaz, Kavya Sugur, Srilakshmi Yalavarthi, Cyrus Sarosh, Tristin Smith, Katarina Kmetova, Emily Chong, Noah F. Peters, Christine E. Rysenga, Gary L. Norman, Gabriel Figueroa ‐Parra, Da Tags: Brief Report Source Type: research